
0:52
In this brief conversation, Speaker A highlights that cholecystokinin (CCK) not only acts as a potent appetite suppressant but also actively stimulates the gallbladder to contract, increasing bile production. They contrast this with injectable weight‑loss therapies, which can lead to gallbladder stasis and reduced bile flow. Dr. Jeffrey Gladden expands on why a functioning gallbladder is essential, explaining its partnership with the pancreas to emulsify dietary fats and facilitate the absorption of fat‑soluble nutrients such as fish oil, vitamins D, A, E, and K. The dialogue underscores the importance of preserving gallbladder activity when using appetite‑modulating agents.










